Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.
ret Oncoprotein Primary Antibodies

ret Oncoprotein Novocastra

Human small intestine: immunohistochemical staining for ret oncoprotein using NCL-RET.  Note cytoplasmic staining of enteric ganglion cells. Paraffin section.
Human small intestine: immunohistochemical staining for ret oncoprotein using NCL-RET. Note cytoplasmic staining of enteric ganglion cells. Paraffin section.

Antigen Background

The ret proto-oncogene encodes a cell surface glycoprotein belonging to the receptor tyrosine kinase family and is located on chromosome 10q11.2. Three main 3' splice isoforms have been characterized from papillary thyroid carcinomas, themselves originating from thyroid epithelial cells. Ret expression is reported in several regions of the central nervous system; in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuroretina and the growing tips of the renal collecting ducts in developing kidney. Some individuals with Hirschsprung's disease have severe developmental abnormalities of the kidney and these phenotypic abnormalities may be linked with mutations of ret proto-oncogene. About 70 percent of individuals who carry one of the documented ret mutations that predispose to multiple endocrine neoplasia type II (MENII) will develop thyroid C cell derived tumors in their lifetime.

Product Specific Information

NCL-RET was raised to the intracellular domain of the molecule, present in all isoforms of the protein. Mutations are reported to occur upstream of this domain.


loading...

CLONE: 3F8

Request a quote

Code Name Configuration Use Datasheet MSDS Qty
RET-U 1ml NCL-RET US IVD Lyophilised Concentrated Monoclonal Antibody P(HIER) Info MSDS
RET-S 0.1ml NCL-RET Lyophilised Concentrated Monoclonal Antibody P(HIER) Info MSDS